2024-09-01 2025-08-31 2025-08-31 false 14269576 Cosmetics HQ Dorset Ltd 96020Hairdressing and other beauty treatment iso4217:GBP xbrli:pure 142695762024-09-01 142695762025-08-31 142695762024-09-01 2025-08-31 14269576bus:SmallEntities2024-09-01 2025-08-31 14269576bus:AuditExempt-NoAccountantsReport2024-09-01 2025-08-31 14269576bus:AbridgedAccounts2024-09-01 2025-08-31 14269576core:WithinOneYear2025-08-31 14269576core:AfterOneYear2025-08-31 14269576core:WithinOneYear2024-09-01 2025-08-31 14269576core:AfterOneYear2024-09-01 2025-08-31 14269576core:CurrentFinancialInstruments2025-08-31 14269576core:Non-currentFinancialInstruments2025-08-31 14269576core:CurrentFinancialInstruments2024-09-01 2025-08-31 14269576core:Non-currentFinancialInstruments2024-09-01 2025-08-31 14269576core:LandBuildings2024-09-01 2025-08-31 14269576core:FurnitureFittings2024-09-01 2025-08-31 14269576core:OfficeEquipment2024-09-01 2025-08-31 14269576core:Vehicles2024-09-01 2025-08-31 14269576core:PlantMachinery2024-09-01 2025-08-31 14269576core:OtherPropertyPlantEquipment2024-09-01 2025-08-31 14269576core:LandBuildings2025-08-31 14269576core:PlantMachinery2025-08-31 14269576core:Vehicles2025-08-31 14269576core:FurnitureFittings2025-08-31 14269576core:OfficeEquipment2025-08-31 14269576core:OtherPropertyPlantEquipment2025-08-31 14269576core:Right-of-useAssets2024-09-01 2025-08-31 14269576core:Right-of-useAssets2025-08-31 14269576core:Goodwill2024-09-01 2025-08-31 14269576core:PatentsTrademarksLicencesConcessionsSimilar2024-09-01 2025-08-31 14269576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-09-01 2025-08-31 14269576core:OtherResidualIntangibleAssets2024-09-01 2025-08-31 14269576core:Goodwill2025-08-31 14269576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-08-31 14269576core:PatentsTrademarksLicencesConcessionsSimilar2025-08-31 14269576core:OtherResidualIntangibleAssets2025-08-31 14269576dpl:CostSales2024-09-01 2025-08-31 14269576dpl:AdministrativeExpenses2024-09-01 2025-08-31 14269576dpl:DistributionCosts2024-09-01 2025-08-3114269576core:ShareCapital2025-08-31 14269576core:SharePremium2025-08-31 14269576core:RevaluationReserve2025-08-31 14269576core:OtherReservesSubtotal2025-08-31 14269576core:ShareCapitalPreferenceShares2025-08-31 14269576core:CapitalRedemptionReserve2025-08-31 14269576core:OtherCapitalReserve2025-08-31 14269576core:RetainedEarningsAccumulatedLosses2025-08-3114269576core:ShareCapital2024-09-01 2025-08-31 14269576core:SharePremium2024-09-01 2025-08-31 14269576core:RevaluationReserve2024-09-01 2025-08-31 14269576core:OtherReservesSubtotal2024-09-01 2025-08-31 14269576core:RetainedEarningsAccumulatedLosses2024-09-01 2025-08-311426957612024-09-01 2025-08-31 1426957622024-09-01 2025-08-3114269576core:ShareCapital12024-09-01 2025-08-31 14269576core:ShareCapital22024-09-01 2025-08-3114269576core:SharePremium12024-09-01 2025-08-31 14269576core:SharePremium22024-09-01 2025-08-3114269576core:RevaluationReserve12024-09-01 2025-08-31 14269576core:RevaluationReserve22024-09-01 2025-08-3114269576core:RetainedEarningsAccumulatedLosses12024-09-01 2025-08-31 14269576core:RetainedEarningsAccumulatedLosses22024-09-01 2025-08-311426957612024-09-01 2025-08-3114269576core:Non-currentFinancialInstrumentscore:CostValuation2024-09-01 14269576core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3114269576core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-09-01 14269576core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-08-31 14269576core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-31 14269576core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-08-3114269576core:Non-currentFinancialInstruments2025-08-31 14269576core:Non-currentFinancialInstruments2024-08-31142695762023-09-01 142695762024-08-31 142695762023-09-01 2024-08-31 14269576core:WithinOneYear2024-08-31 14269576core:AfterOneYear2024-08-31 14269576core:CurrentFinancialInstruments2024-08-31 14269576core:Non-currentFinancialInstruments2024-08-31 14269576core:LandBuildings2024-08-31 14269576core:PlantMachinery2024-08-31 14269576core:Vehicles2024-08-31 14269576core:FurnitureFittings2024-08-31 14269576core:OfficeEquipment2024-08-31 14269576core:OtherPropertyPlantEquipment2024-08-31 14269576core:Right-of-useAssets2024-08-31 14269576core:Goodwill2024-08-31 14269576core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-08-31 14269576core:PatentsTrademarksLicencesConcessionsSimilar2024-08-31 14269576core:OtherResidualIntangibleAssets2024-08-31 14269576dpl:AdministrativeExpenses2023-09-01 2024-08-3114269576core:ShareCapital2024-08-31 14269576core:SharePremium2024-08-31 14269576core:RevaluationReserve2024-08-31 14269576core:OtherReservesSubtotal2024-08-31 14269576core:ShareCapitalPreferenceShares2024-08-31 14269576core:CapitalRedemptionReserve2024-08-31 14269576core:OtherCapitalReserve2024-08-31 14269576core:RetainedEarningsAccumulatedLosses2024-08-3114269576core:RetainedEarningsAccumulatedLosses2023-09-01 14269576core:ShareCapital2023-09-01 14269576core:SharePremium2023-09-01 14269576core:RevaluationReserve2023-09-01 14269576core:ShareCapital2023-09-01 2024-08-31 14269576core:SharePremium2023-09-01 2024-08-31 14269576core:RevaluationReserve2023-09-01 2024-08-31 14269576core:OtherReservesSubtotal2023-09-01 2024-08-31 14269576core:RetainedEarningsAccumulatedLosses2023-09-01 2024-08-311426957612023-09-01 2024-08-31 1426957622023-09-01 2024-08-3114269576core:ShareCapital12023-09-01 2024-08-31 14269576core:ShareCapital22023-09-01 2024-08-3114269576core:SharePremium12023-09-01 2024-08-31 14269576core:SharePremium22023-09-01 2024-08-3114269576core:RevaluationReserve12023-09-01 2024-08-31 14269576core:RevaluationReserve22023-09-01 2024-08-3114269576core:RetainedEarningsAccumulatedLosses12023-09-01 2024-08-31 14269576core:RetainedEarningsAccumulatedLosses22023-09-01 2024-08-3114269576bus:Director12024-09-01 2025-08-3114269576bus:Director22024-09-01 2025-08-3114269576bus:PrivateLimitedCompanyLtd2024-09-01 2025-08-31
Cosmetics HQ Dorset Ltd
Unaudited Financial Statements
for the year ended 31 August 2025
Company registration number 14269576
(England and Wales)

Company Information

For the year ended 31 August 2025
Directors Armitage, Shanice Patricia Carolyn
Melim, Stephen Matthew

Registered office 127 Belle Vue Road
Bournemouth
BH6 3DJ

Registered number 14269576

Accountant HSYN AND CO ACCOUNTANCY

Statement of Financial Position

As at 31 August 2025
Notes
2025
2024
£
£
£
£
Current assets
Debtors
(347)
(141)
(347)
(141)
Creditors
Amounts falling due within one year
4
(8,984)
(8,892)
(8,984)
(8,892)
Net current assets (liabilities)
(9,331)
(9,033)
Total assets less current liabilities
(9,331)
(9,033)
Creditors
Amounts falling due after one year
5
(7,297)
(8,441)
(7,297)
(8,441)
Net assets (liabilities)
(16,628)
(17,474)
Capital and reserves
Called up share capital
200
200
Profit and loss account
(16,828)
(17,674)
Total equity
(16,628)
(17,474)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444 (2A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 15 July 2026 and are signed on its behalf by:

Armitage, Shanice Patricia Carolyn
Armitage, Shanice Patricia Carolyn
Director
Melim, Stephen Matthew
Melim, Stephen Matthew
Director

Company registration number 14269576

Notes to the Financial Statements

For the year ended 31 August 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 0 (2024: 0).

4. Creditors due within one year

2025
2024
£
£
Other creditors
19
19
Directors loan account
2,714
2,664
Taxation and social security
6,251
6,209
Total
8,984
8,892

5. Creditors due after one year

2025
2024
£
£
Bank loans and overdrafts
7,297
8,441
Total
7,297
8,441